First transmission of human immunodeficiency virus Type 1 by a cellular blood product after mandatory nucleic acid screening in Germany.
about
Pilot studies for development of an HIV subtype panel for surveillance of global diversity.Quality and Safety in Blood Supply in 2010Treatment of Ebola virus infection with antibodies from reconvalescent donors.Transmission of human immunodeficiency virus infection by renal transplantation.Molecular virology in transfusion medicine laboratory.Implementation of an HIV-1 Triple-Target NAT Assay in the Routine Screening at Three German Red Cross Blood Centres.Human Immunodeficiency Virus (HIV).Factors in enhancing blood safety by nucleic acid technology testing for human immunodeficiency virus, hepatitis C virus and hepatitis B virus.Risk Minimization Measures for Blood Screening HIV-1 Nucleic Acid Amplification Technique Assays in Germany.Molecular HIV screening.High sensitivity detection of HIV-1 using two genomic targets compared with single target PCR.Motivations for donating and attitudes toward screening policies in US blood donors with viral infection.Detection of emergent strains of West Nile virus with a blood screening assay.Evaluation of the Procleix Ultrio Elite Assay and the Panther-System for Individual NAT Screening of Blood, Hematopoietic Stem Cell, Tissue and Organ Donors.Transmission of human immunodeficiency virus Type-1 by fresh-frozen plasma treated with methylene blue and light.[Human immunodeficiency virus: position of Blood Working Group of the Federal Ministry of Health].Inclusion of human immunodeficiency virus Type 2 (HIV-2) in a multiplex transcription-mediated amplification assay does not affect detection of HIV-1 and hepatitis B and C virus genotypes: a multicenter performance evaluation study.Pathogen inactivation efficacy of Mirasol PRT System and Intercept Blood System for non-leucoreduced platelet-rich plasma-derived platelets suspended in plasma.Trends in prevalence, incidence, and residual risk of major transfusion-transmissible viral infections in United Arab Emirates blood donors: impact of individual-donation nucleic acid testing, 2004 through 2009.Experience of mandatory nucleic acid test (NAT) screening across all blood organizations in Germany: NAT yield versus breakthrough transmissions.Preanalytical stability of HIV-1 and HCV RNA: impact of storage and plasma separation from cells on blood donation testing by NAT.How safe is safe: new human immunodeficiency virus Type 1 variants missed by nucleic acid testing.Hepatitis B virus transmission by blood transfusion during 4 years of individual-donation nucleic acid testing in South Africa: estimated and observed window period risk.Blood screening nucleic acid amplification tests for human immunodeficiency virus Type 1 may require two different amplification targets.A cluster of human immunodeficiency virus Type 1 recombinant form escaping detection by commercial genomic amplification assays.
P2860
Q30514155-54EDD510-04EB-4307-9777-AA63F66A5007Q33929726-43B28885-F91C-4061-8241-614A8FF98DDDQ35130375-1CB6CCD4-8204-47E1-906F-AD36234D4E86Q36082312-1D2FF6AF-22F7-4F2B-972E-C2D21B20DD50Q36766449-083E5CF2-945E-4707-BEB6-7177A4727D27Q37045800-7854ACB0-A82B-4D62-8CA9-2925C36C8AA4Q37045832-8A471659-7417-4959-8949-86E17C7468DFQ37618604-A95A2F93-C878-44C1-BC7B-A893F5F48676Q37630304-41FEB420-1719-4BF8-94CC-6C26D8F32D14Q38142249-275EEB8F-CE8C-4F41-A451-E9BBD6543D30Q38295260-4DF304D4-C733-440A-8B7D-E61D19AF1B03Q39649596-CC0F135B-8956-42B6-9DD1-480B18BA68F9Q40127918-8B2763C3-5F35-4CEF-ABEE-8AAA022ACB17Q40656078-5AC5AEA7-3210-4B31-8959-3037783702EEQ40903377-B5014F7A-8EC4-439D-B2E4-B9AF37469B8EQ40942917-80B9065A-D7F6-430B-A2A9-E91EB913E20DQ41647666-A70CFD8C-F0D4-4E8E-A035-1CD50DD7B7F4Q42220047-C69851A4-FA2F-4DA2-8AF2-D7E4176F829FQ42981169-DB6D319F-30E5-49C3-B3DA-95F69EB1E06CQ42987806-D556DA3F-FDEF-48A4-BF72-39CEF7A6B49BQ43001633-E4FC6373-625C-4975-B1DD-7B666ACD3F3BQ45350673-2C327A7F-332A-4C9C-A934-C618A9BFACD8Q45362712-F4F6DA2F-6952-4D8A-A29A-E67FDCD78B4BQ45364475-46B90B8B-EAF9-4E7A-ACE0-5F1BCAE623BDQ45371172-FDAC0529-EE28-439C-AF5A-A14C212DE144
P2860
First transmission of human immunodeficiency virus Type 1 by a cellular blood product after mandatory nucleic acid screening in Germany.
description
2009 nî lūn-bûn
@nan
2009年の論文
@ja
2009年論文
@yue
2009年論文
@zh-hant
2009年論文
@zh-hk
2009年論文
@zh-mo
2009年論文
@zh-tw
2009年论文
@wuu
2009年论文
@zh
2009年论文
@zh-cn
name
First transmission of human im ...... eic acid screening in Germany.
@en
type
label
First transmission of human im ...... eic acid screening in Germany.
@en
prefLabel
First transmission of human im ...... eic acid screening in Germany.
@en
P2093
P2860
P1433
P1476
First transmission of human im ...... eic acid screening in Germany.
@en
P2093
Andreas Karl
Annemarie Berger
B Karsten Tischer
C Micha Nübling
Erhard Seifried
Geert Geusendam
Hans Wilhelm Doerr
Heinz A Horst
Helmut Fickenscher
Holger F Rabenau
P2860
P304
P356
10.1111/J.1537-2995.2009.02203.X
P577
2009-05-11T00:00:00Z